×
Assembly Biosciences EBITDA 2010-2024 | ASMB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Assembly Biosciences ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Assembly Biosciences EBITDA 2010-2024 | ASMB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Assembly Biosciences ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$11.2B
BridgeBio Pharma (BBIO)
$6.9B
Bausch Health Cos (BHC)
$2.4B
Supernus Pharmaceuticals (SUPN)
$1.9B
Amphastar Pharmaceuticals (AMPH)
$1.5B
Personalis (PSNL)
$412M
Taysha Gene Therapies (TSHA)
$336M
Sol-Gel Technologies (SLGL)
$16M
Evoke Pharma (EVOK)
$8M
Teligent (TLGT)
$0M